Palo Alto, CA, United States of America

Lesley Suzanne Weaver

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lesley Suzanne Weaver: Innovator in Particle Separation Technologies

Introduction

Lesley Suzanne Weaver is a prominent inventor based in Palo Alto, CA. She has made significant contributions to the field of particle separation technologies, holding a total of 3 patents. Her innovative work focuses on utilizing advanced methods to enhance the separation and concentration of particulate samples.

Latest Patents

Weaver's latest patents include a "Particle separator system, materials, and methods of use." This invention relates to systems and methods that utilize magnetic levitation for the separation of particulate containing samples, such as cells or biomolecules. The methods are particularly useful for distinguishing between live and dead cells, as well as isolating particle-depleted mediums. Another notable patent is "Determination of copy number differences by amplification," which provides a method for determining relative copy number differences for target nucleic acid sequences between test and reference samples. This innovation facilitates the detection of copy number differences of less than 1.5-fold.

Career Highlights

Throughout her career, Lesley has worked with notable companies, including Fluidigm Corporation and LevitasBio, Inc. Her experience in these organizations has allowed her to develop and refine her innovative technologies.

Collaborations

Lesley has collaborated with talented individuals such as Simant Dube and Alain Mir, contributing to the advancement of her research and inventions.

Conclusion

Lesley Suzanne Weaver is a trailblazer in the field of particle separation technologies, with a focus on innovative methods that enhance the analysis of biological samples. Her contributions continue to impact the scientific community and advance the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…